What Are Nootropics?

“Nootropic” is commonly used for substances marketed or discussed in relation to cognitive performance. The category spans products with very different evidence, risks and regulatory status.

Evidence is product-specific

Do not treat the word “nootropic” as a guarantee. Evidence should be evaluated by substance, formulation, dose, population and outcome.

Supplements and cognitive decline

NIH guidance says direct evidence that dietary supplements prevent Alzheimer's disease or other forms of dementia is lacking. That makes disease-prevention promises an especially poor basis for choosing a supplement.

A practical evaluation framework

Look for transparent labeling, plausible dosing, human evidence relevant to the intended outcome, safety information, and clear separation between ingredient evidence and finished-product evidence.

For an applied example, see our NeuroZoom review.